HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of Lecanemab for Patients With Cardiovascular Disease: The Challenge of Uncertainty.

AuthorsDarae Ko, Alvaro Pascual-Leone, Sachin J Shah
JournalJAMA (JAMA) Vol. 331 Issue 13 Pg. 1089-1090 (04 02 2024) ISSN: 1538-3598 [Electronic] United States
PMID38488809 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • lecanemab
Topics
  • Humans
  • Alzheimer Disease (drug therapy, epidemiology)
  • Antibodies, Monoclonal, Humanized (adverse effects, therapeutic use)
  • Cardiovascular Diseases (epidemiology, etiology)
  • Cognitive Dysfunction (complications, drug therapy)
  • Uncertainty
  • Comorbidity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: